Literature DB >> 1907941

The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.

L D Kerr1, J Inoue, N Davis, E Link, P A Baeuerle, H R Bose, I M Verma.   

Abstract

The product of proto-oncogene Rel associates with a number of cellular proteins. We have studied the effect of one of them, a phosphoprotein of 40 kD (pp40), on the DNA-binding activity of the Rel protein. We demonstrate that purified pp40 not only inhibits the binding of Rel, but also NF-kappa B (p50-p65) heterocomplex to DNA. Additionally, I kappa B beta, but not I kappa B alpha, also prevented the binding of Rel to the kappa B site. I kappa B beta and pp40 are related proteins because (1) they share a number of common tryptic peptides, (2) their inhibitory effect on DNA binding can be abolished by preincubation with pp40-specific antiserum, and (3) labeled I kappa B beta can be immunoprecipitated with pp40 antibodies. pp40 is part of the Rel complex present in the cytoplasm and nuclear extracts of WEHI-231 cells. The activity of pp40 to inhibit the DNA binding of Rel and NF-kappa B is modulated by phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907941     DOI: 10.1101/gad.5.8.1464

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  98 in total

Review 1.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

2.  Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages.

Authors:  B G Ohlsson; M C Englund; A L Karlsson; E Knutsen; C Erixon; H Skribeck; Y Liu; G Bondjers; O Wiklund
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein.

Authors:  S Kumar; A B Rabson; C Gélinas
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

4.  The C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains.

Authors:  P J Morin; T D Gilmore
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

5.  An indirect negative autoregulatory mechanism involved in hepatocyte nuclear factor-1 gene expression.

Authors:  A A Kritis; E Ktistaki; D Barda; V I Zannis; I Talianidis
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

6.  Tax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3.

Authors:  E Muñoz; G Courtois; P Veschambre; P Jalinot; A Israël
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  CpG-ODN-mediated TLR9 innate immune signalling and calcium dyshomeostasis converge on the NFκB inhibitory protein IκBβ to drive IL1α and IL1β expression.

Authors:  Robyn De Dios; Leanna Nguyen; Sankar Ghosh; Sarah McKenna; Clyde J Wright
Journal:  Immunology       Date:  2020-03-18       Impact factor: 7.397

8.  Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities.

Authors:  R J Grumont; S Gerondakis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.

Authors:  G P Nolan; T Fujita; K Bhatia; C Huppi; H C Liou; M L Scott; D Baltimore
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.

Authors:  A A Beg; T S Finco; P V Nantermet; A S Baldwin
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.